Open-Label Study of Safety of H1337 in Healthy Volunteers

An Open-Label Study Assessing the Ocular and Systemic Safety and Systemic Absorption of H1337 Ophthalmic Solution, 1% in Healthy Volunteers

The trial will evaluate the safety of one dose regimen of H-1337 [1% twice daily (b.i.d.)] in both eyes in healthy volunteers.

Inclusion Criteria:

• Healthy adult male or female subjects
• Subjects in good ocular and systemic health with clinically insignificant medical and ophthalmic history

Exclusion Criteria:

• Chronic or acute ophthalmic disease in each eye including but not limited to any form of glaucoma, retinal diseases, clinically significant cataract (primary or secondary)
• Recent intraocular surgery in either eye (within 6 months)

Note: Other inclusion/exclusion criteria apply.